TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The PAL Trial (Physical Activity and Lymphedema)
Brief Summary: The purpose of the PAL trial is to increase the understanding of the experiences of long-term breast cancer survivors.

Study hypothesis: Strength training will not increase the rate of lymphedema or worsen lymphedema as compared to the non-exercising control participants.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial rehabilitation course | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychosocial rehabilitation course; Assigned to Arm(s): Intervention group
B: Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): N/A
C: Arm Label: Group I (yoga-based rehabilitation program); Type: EXPERIMENTAL; Interventions: Procedure: Quality-of-Life Assessment, Procedure: Yoga | Arm Label: Group II (standard care/control); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Quality-of-Life Assessment, Procedure: Yoga | Intervention Type: PROCEDURE; Name: Quality-of-Life Assessment; Assigned to Arm(s): Group I (yoga-based rehabilitation program), Group II (standard care/control) | Intervention Type: PROCEDURE; Name: Yoga; Assigned to Arm(s): Group I (yoga-based rehabilitation program), Group II (standard care/control)
D: Arm Label: Arm I: Yoga Therapy; Type: EXPERIMENTAL; Interventions: Procedure: Yoga Therapy | Arm Label: Arm II: Wait-List; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Yoga Therapy; Assigned to Arm(s): Arm I: Yoga Therapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The PAL Trial (Physical Activity and Lymphedema)
Brief Summary: The purpose of the PAL trial is to increase the understanding of the experiences of long-term breast cancer survivors.

Study hypothesis: Strength training will not increase the rate of lymphedema or worsen lymphedema as compared to the non-exercising control participants.


Options:
A: Arm Label: All patients; Type: N/A; Interventions: N/A
B: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Attention Control (Health Education); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control (Health Education) | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Attention Control (Health Education); Assigned to Arm(s): Attention Control (Health Education)
C: Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): N/A
D: Arm Label: Tamoxifen; Type: ACTIVE_COMPARATOR; Interventions: Other: Laboratory Biomarker Analysis, Other: Quality-of-Life Assessment, Drug: Tamoxifen | Arm Label: T+OFS; Type: EXPERIMENTAL; Interventions: Other: Laboratory Biomarker Analysis, Procedure: Oophorectomy, Other: Quality-of-Life Assessment, Radiation: Radiation Therapy, Drug: Tamoxifen, Drug: Triptorelin | Arm Label: E+OFS; Type: EXPERIMENTAL; Interventions: Drug: Exemestane, Other: Laboratory Biomarker Analysis, Procedure: Oophorectomy, Other: Quality-of-Life Assessment, Radiation: Radiation Therapy, Drug: Triptorelin | Intervention Type: DRUG; Name: Exemestane; Assigned to Arm(s): E+OFS | Intervention Type: OTHER; Name: Laboratory Biomarker Analysis; Assigned to Arm(s): E+OFS, T+OFS, Tamoxifen | Intervention Type: PROCEDURE; Name: Oophorectomy; Assigned to Arm(s): E+OFS, T+OFS | Intervention Type: OTHER; Name: Quality-of-Life Assessment; Assigned to Arm(s): E+OFS, T+OFS, Tamoxifen | Intervention Type: RADIATION; Name: Radiation Therapy; Assigned to Arm(s): E+OFS, T+OFS | Intervention Type: DRUG; Name: Tamoxifen; Assigned to Arm(s): T+OFS, Tamoxifen | Intervention Type: DRUG; Name: Triptorelin; Assigned to Arm(s): E+OFS, T+OFS

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The PAL Trial (Physical Activity and Lymphedema)
Brief Summary: The purpose of the PAL trial is to increase the understanding of the experiences of long-term breast cancer survivors.

Study hypothesis: Strength training will not increase the rate of lymphedema or worsen lymphedema as compared to the non-exercising control participants.


Options:
A: Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): N/A
B: Arm Label: Football; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Football | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Football; Assigned to Arm(s): Football
C: Arm Label: Exercising Together; Type: EXPERIMENTAL; Interventions: Behavioral: Randomized Exercise Intervention | Arm Label: Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Randomized Exercise Intervention | Intervention Type: BEHAVIORAL; Name: Randomized Exercise Intervention; Assigned to Arm(s): Exercising Together | Intervention Type: BEHAVIORAL; Name: Randomized Exercise Intervention; Assigned to Arm(s): Usual Care
D: Arm Label: Arm I (strength training); Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention, Other: Questionnaire Administration | Arm Label: Arm II (tai chi); Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Intervention, Other: Questionnaire Administration | Arm Label: Arm III (control); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Intervention, Other: Questionnaire Administration | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Arm I (strength training) | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Arm II (tai chi) | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Arm III (control) | Intervention Type: OTHER; Name: Questionnaire Administration; Assigned to Arm(s): Arm I (strength training), Arm II (tai chi), Arm III (control)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The PAL Trial (Physical Activity and Lymphedema)
Brief Summary: The purpose of the PAL trial is to increase the understanding of the experiences of long-term breast cancer survivors.

Study hypothesis: Strength training will not increase the rate of lymphedema or worsen lymphedema as compared to the non-exercising control participants.


Options:
A: Intervention Type: BEHAVIORAL; Name: Strength training; Assigned to Arm(s): N/A
B: Arm Label: Rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: RePCa A | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: RePCa A | Intervention Type: BEHAVIORAL; Name: RePCa A; Assigned to Arm(s): Control, Rehabilitation
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise Behavior Change | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise Behavior Change; Assigned to Arm(s): 1
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons
Brief Summary: The purpose of this trial is to study the safety, tolerability and efficacy of an almond enriched hypocaloric diet on weight loss and weight maintenance, as well as on established and emerging cardiovascular risk factors in approximately 112 overweight and obese persons.


Options:
A: Arm Label: Control diet; Type: ACTIVE_COMPARATOR; Interventions: Other: control diet | Arm Label: Pistachio diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Pistachios | Intervention Type: DIETARY_SUPPLEMENT; Name: Pistachios; Assigned to Arm(s): Pistachio diet | Intervention Type: OTHER; Name: control diet; Assigned to Arm(s): Control diet
B: Arm Label: Consumption of 42 g of salted peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of unsalted peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of spicy peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of honey peanuts; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of 3 diff. varieties; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Arm Label: Consumption of 42 g of var. of types; Type: EXPERIMENTAL; Interventions: Other: Consumption of 42 grams of peanuts daily | Intervention Type: OTHER; Name: Consumption of 42 grams of peanuts daily; Assigned to Arm(s): Consumption of 42 g of 3 diff. varieties, Consumption of 42 g of honey peanuts, Consumption of 42 g of salted peanuts, Consumption of 42 g of spicy peanuts, Consumption of 42 g of unsalted peanuts, Consumption of 42 g of var. of types
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Almond enriched diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low fat caloric diet | Intervention Type: BEHAVIORAL; Name: Almond enriched diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low fat caloric diet; Assigned to Arm(s): 2
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: healthy life style education | Arm Label: B; Type: SHAM_COMPARATOR; Interventions: Behavioral: healthy life style education | Intervention Type: BEHAVIORAL; Name: healthy life style education; Assigned to Arm(s): A, B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Psychosocial/Behavioral Intervention in PSD
Brief Summary: The primary aim of this study is to determine the effect of a nurse-delivered psychosocial/behavioral intervention on reduction of depression in community dwelling post-stroke patients. We expect the combined behavioral and pharmacologic intervention to be more effective than pharmacotherapy alone in sustaining the improvement in depression for the experimental group. Secondary aims are to examine the effect of the psychosocial/behavioral intervention time course and sustainability of response to treatment, effect on limitations in ability, limitation in participation and overall stroke impact in community-dwelling post-stroke patients, and to compare ischemic stroke survivors who are and are not depressed within the first four months following stroke by their 5-HTTLPR genotypes (s/s, s/l, or l/l).


Options:
A: Arm Label: Recovering Together; Type: EXPERIMENTAL; Interventions: Behavioral: Recovering Together | Arm Label: Health Education; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Recovering Together; Assigned to Arm(s): Recovering Together
B: N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Modified cognitive behavioral therapy plus problem-solving | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: usual care | Intervention Type: BEHAVIORAL; Name: Modified cognitive behavioral therapy plus problem-solving; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: usual care; Assigned to Arm(s): 2
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: fluoxetine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: fluoxetine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Psychosocial/Behavioral Intervention in PSD
Brief Summary: The primary aim of this study is to determine the effect of a nurse-delivered psychosocial/behavioral intervention on reduction of depression in community dwelling post-stroke patients. We expect the combined behavioral and pharmacologic intervention to be more effective than pharmacotherapy alone in sustaining the improvement in depression for the experimental group. Secondary aims are to examine the effect of the psychosocial/behavioral intervention time course and sustainability of response to treatment, effect on limitations in ability, limitation in participation and overall stroke impact in community-dwelling post-stroke patients, and to compare ischemic stroke survivors who are and are not depressed within the first four months following stroke by their 5-HTTLPR genotypes (s/s, s/l, or l/l).


Options:
A: Arm Label: Dialogue-based psychosocial intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dialogue-based psychosocial rehabilitation | Arm Label: Usual care Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialogue-based psychosocial rehabilitation; Assigned to Arm(s): Dialogue-based psychosocial intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Modified cognitive behavioral therapy plus problem-solving | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: usual care | Intervention Type: BEHAVIORAL; Name: Modified cognitive behavioral therapy plus problem-solving; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: usual care; Assigned to Arm(s): 2
C: Arm Label: escitalopram; Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: sugar pill | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): escitalopram | Intervention Type: DRUG; Name: sugar pill; Assigned to Arm(s): placebo
D: Arm Label: In-person behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Telephone behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: BEHAVIORAL; Name: Brief pleasurable events/behavioral therapy; Assigned to Arm(s): In-person behavioral intervention, Telephone behavioral intervention | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home
Brief Summary: This is a 12-month randomized, controlled trial of a Web-based diabetes co-management module among type 2 patients at the University of Washington's Roosevelt General Internal Medicine Clinic.


Options:
A: Arm Label: Intervention; Type: OTHER; Interventions: Behavioral: Vascular Management Program, Behavioral: Clinical Care Coordinators, Behavioral: Web-based Vascular Tracker for Patient and Physician, Behavioral: Automated Telephone Reminder System | Intervention Type: BEHAVIORAL; Name: Vascular Management Program; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Clinical Care Coordinators; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Web-based Vascular Tracker for Patient and Physician; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Automated Telephone Reminder System; Assigned to Arm(s): Intervention
B: Intervention Type: BEHAVIORAL; Name: Internet co-management module; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Peer-led Support Group, Other: Behavioral Health Consult, Other: Medication Therapy Management Consult, Other: La Cocina Alegre/ The Happy Kitchen, Other: Mind, Exercise, Nutrition, Do it! | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Peer-led Support Group; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Behavioral Health Consult; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Medication Therapy Management Consult; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: La Cocina Alegre/ The Happy Kitchen; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mind, Exercise, Nutrition, Do it!; Assigned to Arm(s): Intervention
D: Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Behavioral: Telemedicine | Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Telemedicine; Assigned to Arm(s): Telemedicine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home
Brief Summary: This is a 12-month randomized, controlled trial of a Web-based diabetes co-management module among type 2 patients at the University of Washington's Roosevelt General Internal Medicine Clinic.


Options:
A: Intervention Type: BEHAVIORAL; Name: Internet co-management module; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Web Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: web intervention | Arm Label: Nurse Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: nurse intervention | Intervention Type: BEHAVIORAL; Name: web intervention; Assigned to Arm(s): Web Intervention | Intervention Type: BEHAVIORAL; Name: nurse intervention; Assigned to Arm(s): Nurse Intervention
C: Arm Label: Home Telemonitoring; Type: EXPERIMENTAL; Interventions: Device: Intel Health Guide | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: DEVICE; Name: Intel Health Guide; Assigned to Arm(s): Home Telemonitoring | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Intervention Type: BEHAVIORAL; Name: Internet-based Dyspnea Self-Management Program; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Face-to-face Dyspnea Self-Management Program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home
Brief Summary: This is a 12-month randomized, controlled trial of a Web-based diabetes co-management module among type 2 patients at the University of Washington's Roosevelt General Internal Medicine Clinic.


Options:
A: Arm Label: Electronic disease management decision support; Type: OTHER; Interventions: Other: Electronic disease management decision support | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Electronic disease management decision support; Assigned to Arm(s): Electronic disease management decision support
B: Intervention Type: BEHAVIORAL; Name: Internet co-management module; Assigned to Arm(s): N/A
C: Intervention Type: DEVICE; Name: OneTouch(r) UltraSmart(r); Assigned to Arm(s): N/A
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemedicine group; Type: ACTIVE_COMPARATOR; Interventions: Device: Telemedicine system | Intervention Type: DEVICE; Name: Telemedicine system; Assigned to Arm(s): Telemedicine group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home
Brief Summary: This is a 12-month randomized, controlled trial of a Web-based diabetes co-management module among type 2 patients at the University of Washington's Roosevelt General Internal Medicine Clinic.


Options:
A: Arm Label: Integrated Cessation Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Treatment | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tobacco Treatment | Intervention Type: BEHAVIORAL; Name: Tobacco Treatment; Assigned to Arm(s): Integrated Cessation Counseling, Usual Care
B: Arm Label: Standard tablet computer; Type: EXPERIMENTAL; Interventions: Other: Standard tablet computer | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Enhanced tablet computer; Type: EXPERIMENTAL; Interventions: Other: Enhanced tablet computer | Intervention Type: OTHER; Name: Standard tablet computer; Assigned to Arm(s): Standard tablet computer | Intervention Type: OTHER; Name: Enhanced tablet computer; Assigned to Arm(s): Enhanced tablet computer
C: Intervention Type: BEHAVIORAL; Name: Internet co-management module; Assigned to Arm(s): N/A
D: Arm Label: Integrated self management support; Type: OTHER; Interventions: Other: Integrated self management support | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated self management support; Assigned to Arm(s): Integrated self management support

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Randomized Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV-Discordant Couples
Brief Summary: The University of Washington has received funding to conduct a proof-of-concept trial to assess the impact of suppression of genital herpes on HIV infectiousness. This study (the Partners in Prevention Study) will enroll HIV discordant heterosexual couples in which the HIV-infected partner is co-infected with herpes simplex virus type 2 (HSV-2) to test the efficacy of twice daily (bid) acyclovir (400 mg) given to the HIV-infected partner to prevent transmission to his/her HIV negative partner(s). This randomized, double-blind, placebo-controlled proof-of-concept trial will provide evidence for the efficacy of HSV-2 suppression with daily acyclovir on HIV transmission among HIV-discordant couples among whom the HIV-positive partner is also HSV-2 seropositive with CD4 \>250. The researchers hypothesis is that, by decreasing the frequency and amount of genital HIV shedding, standard doses of daily acyclovir 400 mg bid will reduce the rate of HIV transmission by 50% in HIV-discordant couples among whom the HIV-infected partner is HSV-2 positive.

Under the study protocol version 4.1.1, 3000 HIV-discordant heterosexual couples in which the HIV-positive partner is HSV-2 positive and has a CD4 count \>250 will be recruited; participants will be followed for up to 2 years. A 4% per year HIV incidence in the placebo arm is assumed.

The first study site began enrolling participants on 17 November 2005. As of September 2006, 14 sites in Eastern and Southern Africa had participated in recruiting the 2300 HIV-discordant couples enrolled to date.


Options:
A: Intervention Type: PROCEDURE; Name: Adult male circumcision; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Valacyclovir; Assigned to Arm(s): N/A
C: Arm Label: Acyclovir; Type: ACTIVE_COMPARATOR; Interventions: Drug: Generic acyclovir | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Generic acyclovir; Assigned to Arm(s): Acyclovir | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: I; Type: EXPERIMENTAL; Interventions: Drug: Valacyclovir, Drug: Matching Placebo | Intervention Type: DRUG; Name: Valacyclovir; Assigned to Arm(s): I | Intervention Type: DRUG; Name: Matching Placebo; Assigned to Arm(s): I

Answer: C